Association of androgen deprivation therapy with cardiovascular death in patients with prostate cancer: a meta-analysis of randomized trials.

Nguyen, Paul L; Je, Youjin; Schutz, Fabio A B; Hoffman, Karen E; Hu, Jim C; Parekh, Arti; Beckman, Joshua A; Choueiri, Toni K

Nguyen, Paul L; Je, Youjin; Schutz, Fabio A B; Hoffman, Karen E; Hu, Jim C; Parekh, Arti; Beckman, Joshua A; Choueiri, Toni K.

Affiliation

Nguyen PL; Department of Radiation Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115, USA. pnguyen@LROC.harvard.edu

JAMA ; 306(21): 2359-66, 2011 Dec 07.

Article in En | MEDLINE | ID: mdl-22147380

Subject(s)

Androgen Antagonists/adverse effects; Cardiovascular Diseases/mortality; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms/mortality; Randomized Controlled Trials as Topic; Androgen Antagonists/therapeutic use; Cause of Death; Gonadotropin-Releasing Hormone/agonists; Humans; Male; Risk; Treatment Outcome

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Cardiovascular Diseases / Randomized Controlled Trials as Topic / Androgen Antagonists Type of study: Clinical_trials / Etiology_studies / Risk_factors_studies / Systematic_reviews Limits: Humans / Male Language: En Journal: JAMA Year: 2011 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google